{"id":"https://genegraph.clinicalgenome.org/r/bd81ce2b-1dca-4ffd-9eab-cbc041cdf466v1.0","type":"EvidenceStrengthAssertion","dc:description":"The relationship between the AGA gene and aspartylglucosaminuria (AGU), an autosomal recessive lysosomal storage disorder, was evaluated using the ClinGen Clinical Validity Framework as of August 7, 2022. AGA encodes aspartylglucosaminidase, an enzyme involved in the breakdown of N-linked oligosaccharides of glycoproteins via cleaving asparagine from the N-acetylglucosamine (PMID: 1703489). Individuals with AGU show deficient aspartylglucosaminidase enzyme activity, leading to accumulation of aspartylglucosamine and other glycoasparagines in multiple tissues and in the urine (PMID: 8405810, PMID: 27906067), which results in the characteristic disease manifestations including progressive neurological impairment and skeletal and connective tissue anomalies (as reviewed in PMID: 27906067). \n\nThe disease mechanism of AGU is loss of function. AGU was first reported in 1967 by Jenner and Pollitt (Jenner, F. A., Pollitt, R. J. Large quantities of 2-acetamido-1-(beta-L-aspartamido)-1,2-dideoxyglucose in the urine of mentally retarded siblings. Biochem. J. 103: 48P-49P, 1967.) and 1968 by Pollitt et al. (PMID: 4173687) and the first reports of biallelic variants in AGA among cases with AGU in 1991 by Ikonen et al. (PMID: 1703489) and Fisher and Aronson (PMID: 1904874). Both case-level (genetic) and experimental evidence support the relationship between AGA and AGU. Reported causal variants include missense, nonsense, frameshift, and splice-altering variants (PMID: 1703489, PMID: 1722323, PMID: 8830180, PMID: 7627186, PMID: 29247835, PMID: 11309371). In total, ten variants from eight probands in six publications were curated. Although there is additional published case-level evidence available, the maximum score for genetic evidence (12 points) has already been reached. \n\nExperimental evidence for the relationship between AGA and AGU includes: the biochemical function of the gene product (aspartylglucosaminidase) being consistent with the clinical and biochemical findings identified individuals with AGU (PMID: 8405810, PMID: 27906067); the biochemical and clinical features of AGA knockout mice (PMID: 8946839); and rescue of systemic accumulation of mannose N-linked oligosaccharides via enzyme replacement therapy in AGA knockout mice (PMID: 20607610). Additional experimental evidence is available, but the maximum score for experimental evidence (6 points) has already been reached.\n\nIn sum, AGA is definitively associated with AGU. The association has been repeatedly demonstrated in both clinical and research settings, and has been upheld over time. This clinical validity classification was approved by the ClinGen Lysosomal Diseases GCEP on September 2, 2022 (SOP v9).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/bd81ce2b-1dca-4ffd-9eab-cbc041cdf466","GCISnapshot":"https://genegraph.clinicalgenome.org/r/1f315b4a-1a3b-4deb-90fd-2b73f732a4ba","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/1f315b4a-1a3b-4deb-90fd-2b73f732a4ba_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10110","date":"2022-09-02T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/1f315b4a-1a3b-4deb-90fd-2b73f732a4ba_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10110","date":"2022-09-29T14:32:20.946Z","role":"Publisher"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1f315b4a-1a3b-4deb-90fd-2b73f732a4ba_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/900b33b5-197b-4655-aad8-55e967654640_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/86d20429-f4de-45e9-be3b-56daca8305c3","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/86d20429-f4de-45e9-be3b-56daca8305c3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/1722323","allele":{"id":"https://genegraph.clinicalgenome.org/r/bd234cfb-5a16-4b5a-adaa-f87fe5de8876","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000027.4(AGA):c.102_108del (p.Thr33_Trp34insTer)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA212726"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/47f02e9c-dee3-4835-b1ff-083d4fdb5ca8","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/47f02e9c-dee3-4835-b1ff-083d4fdb5ca8_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Missense variant shown to result in undetectable enzyme activity when expressed in COS-1 cells (PMID: 8457202)","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/47f02e9c-dee3-4835-b1ff-083d4fdb5ca8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/1722323","allele":{"id":"https://genegraph.clinicalgenome.org/r/e154e3c7-d77f-470c-8b50-9d1eb024b02b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000027.4(AGA):c.302C>T (p.Ala101Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA114059"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/900b33b5-197b-4655-aad8-55e967654640","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/1722323","rdfs:label":"Patient AM","allele":[{"id":"https://genegraph.clinicalgenome.org/r/bd234cfb-5a16-4b5a-adaa-f87fe5de8876"},{"id":"https://genegraph.clinicalgenome.org/r/e154e3c7-d77f-470c-8b50-9d1eb024b02b"}],"firstTestingMethod":"PCR","previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/47f02e9c-dee3-4835-b1ff-083d4fdb5ca8_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/86d20429-f4de-45e9-be3b-56daca8305c3_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.0},{"id":"https://genegraph.clinicalgenome.org/r/5d69c145-09ed-4d8a-aa56-b5ac4b0df422_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0e9ef6fe-5ece-4f4f-bd4c-2df136ade4b4","type":"EvidenceLine","dc:description":"Scored 0.75pts/variant to yield 1.5pts total and prevent double-counting for homozygous variant","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0e9ef6fe-5ece-4f4f-bd4c-2df136ade4b4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/1722323","allele":{"id":"https://genegraph.clinicalgenome.org/r/ddaefab0-5391-46af-8861-92bcccc6a260","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000027.4(AGA):c.800del (p.Leu267fs)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA212729"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/5d69c145-09ed-4d8a-aa56-b5ac4b0df422","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/1722323","rdfs:label":"Patient RV","allele":{"id":"https://genegraph.clinicalgenome.org/r/ddaefab0-5391-46af-8861-92bcccc6a260"},"firstTestingMethod":"PCR","previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/0e9ef6fe-5ece-4f4f-bd4c-2df136ade4b4_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/916d093e-c9aa-4b08-907b-8742c21a72da_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/80b62469-4f40-4f45-a7b4-c718dec91a27","type":"EvidenceLine","dc:description":"Scored 1pt/variant to yield 2pts total and prevent double-counting for homozygous variant ","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/80b62469-4f40-4f45-a7b4-c718dec91a27_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"PMID: 8830180: When expressed in COS-1 cells, did not undergo post-translational processing and resulted in undetectable AGA enzyme activity","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/80b62469-4f40-4f45-a7b4-c718dec91a27_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8830180","allele":{"id":"https://genegraph.clinicalgenome.org/r/a2dc56f2-0986-4ec2-a3d7-f8918090e407","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000027.4(AGA):c.788del (p.Ile262_Leu263insTer)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA144034"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/916d093e-c9aa-4b08-907b-8742c21a72da","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8830180","rdfs:label":"Patient UK3","allele":{"id":"https://genegraph.clinicalgenome.org/r/a2dc56f2-0986-4ec2-a3d7-f8918090e407"},"firstTestingMethod":"PCR","previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/80b62469-4f40-4f45-a7b4-c718dec91a27_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/e368a61c-5f5f-4d7d-8c65-db712f773cad_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/30c1b44c-ba9c-4a40-9edc-f9670462a2b1","type":"EvidenceLine","dc:description":"Scored 0.75pts/variant to yield 1.5pts total and prevent double-counting for homozygous variant","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/30c1b44c-ba9c-4a40-9edc-f9670462a2b1_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"shown via Northern blot analysis of patient’s mRNA to result in exon skipping, frameshift, and premature truncation with NMD predicted","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/30c1b44c-ba9c-4a40-9edc-f9670462a2b1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/1722323","allele":{"id":"https://genegraph.clinicalgenome.org/r/0e8820e0-220c-4306-b82b-1b9a0901425f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000027.4(AGA):c.940+1G>T","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA212728"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/e368a61c-5f5f-4d7d-8c65-db712f773cad","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/1722323","rdfs:label":"Patient BR","allele":{"id":"https://genegraph.clinicalgenome.org/r/0e8820e0-220c-4306-b82b-1b9a0901425f"},"firstTestingMethod":"PCR","previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/30c1b44c-ba9c-4a40-9edc-f9670462a2b1_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/319b1f47-3695-4c5a-92d3-4a5880996936_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a20ac5cf-2a23-4d81-9240-0745647794c4","type":"EvidenceLine","dc:description":"Scored 0.25pts/variant to yield 0.5pts total and prevent double-counting homozygous variant","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a20ac5cf-2a23-4d81-9240-0745647794c4_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"PMID: 1765378: COS-7 cells transfected with the variant showed enzyme activity indistinguishable from background level (seen in cells transfected with AGA cDNA in the antisense orientation).","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/a20ac5cf-2a23-4d81-9240-0745647794c4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/1703489","allele":{"id":"https://genegraph.clinicalgenome.org/r/f43f2c8d-0c9b-44be-88d4-e4e1c64b6de7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000027.4(AGA):c.488G>C (p.Cys163Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA114055"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/319b1f47-3695-4c5a-92d3-4a5880996936","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/1703489","rdfs:label":"Patient 1 - Ikonen","allele":{"id":"https://genegraph.clinicalgenome.org/r/f43f2c8d-0c9b-44be-88d4-e4e1c64b6de7"},"firstTestingMethod":"PCR","previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/a20ac5cf-2a23-4d81-9240-0745647794c4_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/fa45e8ca-412a-4127-9052-99a78110bee5_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b5d13c4a-1378-4ed6-bf88-4fb7514c511b","type":"EvidenceLine","dc:description":"Scored 0.75pts/variant to yield 1.5pts total and prevent double-counting for homozygous variant","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b5d13c4a-1378-4ed6-bf88-4fb7514c511b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11309371","allele":{"id":"https://genegraph.clinicalgenome.org/r/91c67965-db40-4d95-b5a1-961850fe3b03","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000027.4(AGA):c.373_376del (p.Thr125fs)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA144020"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/fa45e8ca-412a-4127-9052-99a78110bee5","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11309371","rdfs:label":"Patient 1 - Saarela","allele":{"id":"https://genegraph.clinicalgenome.org/r/91c67965-db40-4d95-b5a1-961850fe3b03"},"firstTestingMethod":"PCR","previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/b5d13c4a-1378-4ed6-bf88-4fb7514c511b_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/f8081034-2f4e-456c-b5e7-b5fef62584c0_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7221f135-0e77-4156-84a3-c5ce85c6370a","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7221f135-0e77-4156-84a3-c5ce85c6370a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29247835","allele":{"id":"https://genegraph.clinicalgenome.org/r/323ffeb9-b3cd-4c6e-a080-e1be91e472b2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000027.4(AGA):c.503G>A (p.Trp168Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA144027"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/a8decd5e-4988-40d4-bb95-d87919d7da4c","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a8decd5e-4988-40d4-bb95-d87919d7da4c_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"PMID: 8776587: when expressed in COS-1 cells, altered proteolytic processing - resulted in the precursor polypeptide being cleaved being into two subunits corresponding to the 24 kDa α subunit and ‘an abnormally large β subunit, which migrated more slowly than the 17 kDa β subunit of the wild-type enzyme’","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/a8decd5e-4988-40d4-bb95-d87919d7da4c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29247835","allele":{"id":"https://genegraph.clinicalgenome.org/r/7b71d424-cf58-4d12-add8-8617cff5becb","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000027.4(AGA):c.214T>C (p.Ser72Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA114062"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/f8081034-2f4e-456c-b5e7-b5fef62584c0","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29247835","rdfs:label":"Patient 1-Banning","allele":[{"id":"https://genegraph.clinicalgenome.org/r/323ffeb9-b3cd-4c6e-a080-e1be91e472b2"},{"id":"https://genegraph.clinicalgenome.org/r/7b71d424-cf58-4d12-add8-8617cff5becb"}],"firstTestingMethod":"PCR","previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/7221f135-0e77-4156-84a3-c5ce85c6370a_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/a8decd5e-4988-40d4-bb95-d87919d7da4c_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.0},{"id":"https://genegraph.clinicalgenome.org/r/e499b249-8278-474e-a73f-773b32ca916b_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/16fbf1fa-8aa8-4c60-a14d-20dcf1b93cc2","type":"EvidenceLine","dc:description":"Scored 0.75pts/variant to yield 1.5pts total and prevent double-counting for homozygous variant","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/16fbf1fa-8aa8-4c60-a14d-20dcf1b93cc2_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Shown to reduce AGA expression (measured by quantifying mRNA from patient cells) to 3-11% of wild-type ","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/16fbf1fa-8aa8-4c60-a14d-20dcf1b93cc2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7627186","allele":{"id":"https://genegraph.clinicalgenome.org/r/e1f29c8e-fb3b-4221-a938-90fdaddf3373","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000027.4(AGA):c.200_201del (p.Glu67fs)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA144014"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/e499b249-8278-474e-a73f-773b32ca916b","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7627186","rdfs:label":"Patient 1-Isoniemi","allele":{"id":"https://genegraph.clinicalgenome.org/r/e1f29c8e-fb3b-4221-a938-90fdaddf3373"},"detectionMethod":"PCR and solid-phase minisequencing of AGA cDNA ","firstTestingMethod":"PCR","previousTesting":false,"secondTestingMethod":"Other","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/16fbf1fa-8aa8-4c60-a14d-20dcf1b93cc2_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/1f315b4a-1a3b-4deb-90fd-2b73f732a4ba_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1f315b4a-1a3b-4deb-90fd-2b73f732a4ba_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3e446054-16e4-4d00-9b2c-f85c4f4aa4c4","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/006b111f-8856-4b75-87ff-e170a0b27e47","type":"Finding","dc:description":"AGA knockout mice show undetectable AGA gene expression, undetectable AGA enzyme activity, accumulation of aspartylglucosamine in brain, liver, and urine, lysosomal vacuolization, and progressive impairment of neuromotor function, recapitulating key features of the human disease phenotype. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8946839","rdfs:label":"AGA knockout mouse model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/0299d5b9-5419-49dd-868b-7c2559f80437","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7fd61a9a-fe77-4585-b2c0-161325b95813","type":"Finding","dc:description":"Knockout mice treated with ERT showed restored AGA enzyme activity, complete degradation of accumulated substrate (GlcNac-Asn) in the liver and spleen, and 93% reduction in urinary aspartylglucosamine. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20607610","rdfs:label":"Enzyme replacement therapy (ERT) in AGA knockout mice","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityNonHumanRescueCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/1f315b4a-1a3b-4deb-90fd-2b73f732a4ba_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d34196e0-bd72-4d0d-80a8-f9086546befe","type":"EvidenceLine","dc:description":"Per ClinGen LD GCEP guidelines, gene products that have a well-established function in a metabolic pathway are scored 2 points","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1508ff67-5f0e-4cdd-b86e-a4929536a3ca","type":"Finding","dc:description":"AGA encodes aspartylglucosaminidase, an enzyme involved in the breakdown of N-linked oligosaccharides of glycoproteins via cleaving asparagine from the N-acetylglucosamine (PMID: 1703489). Patients with aspartylglucosaminuria (AGU) show deficient aspartylglucosaminidase enzyme activity, leading to accumulation of aspartylglucosamine and other glycoasparagines in multiple tissues and in the urine (PMID: 8405810, PMID: 27906067), which results in the characteristic disease manifestations including progressive neurological impairment and skeletal and connective tissue anomalies. Thus, the function of the AGA gene as an aspartylglucosaminidase is consistent with the accumulation of aspartylglucosamine and other glycoasparagines among AGU patients secondary to deficient aspartylglucosaminidase enzyme activity. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/1703489","rdfs:label":"AGA encodes aspartylglucosaminidase","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":6}],"evidenceStrength":"Definitive","sequence":5101,"specifiedBy":"GeneValidityCriteria9","strengthScore":18,"subject":{"id":"https://genegraph.clinicalgenome.org/r/tilDA917APs","type":"GeneValidityProposition","disease":"obo:MONDO_0008830","gene":"hgnc:318","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_1f315b4a-1a3b-4deb-90fd-2b73f732a4ba-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}